Gosogliptin - Pfizer/SatRx
Alternative Names: DPP IV inhibitor - Pfizer; PF-00734200; PF-734,200; SatRxLatest Information Update: 05 Nov 2023
At a glance
- Originator Pfizer
- Developer Pfizer; SatRx
- Class Antihyperglycaemics; Pyrrolidines; Small molecules
- Mechanism of Action Dipeptidyl peptidase 4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Registered Type 2 diabetes mellitus